The ability of Hoxa9 and Hoxa10 to immortalize myeloid progenitors in vitro suggested that they may also help confer limitless self-renewal potential to GMP-derived LICs in CML myeloid blast crisis. The gene discussed is HOXA9; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.